Leo on the expanded Phase 1 trial:
"We completed everything we set out to do in our Phase 1 trial with Kevetrin in solid tumors. The solid tumor trial is still open, and we are in discussions with the hospital and the trial's principal investigator. They have requested that we do certain scientific experiments. That's a great sign, because it shows the potential of this compound. To have an expanded Phase 1 when you've already met all the goals of the study, for scientific reasons and hopefully for better patient results, is a great thing. We want to characterize the compound more completely, and we want the physicians to understand it as well. This is unusual, and this does not happen frequently, and it's a real honor."
http://www.thelifesciencesreport.com/pub/na/a...-jorgensen
"We completed everything we set out to do in our Phase 1 trial with Kevetrin in solid tumors. The solid tumor trial is still open, and we are in discussions with the hospital and the trial's principal investigator. They have requested that we do certain scientific experiments. That's a great sign, because it shows the potential of this compound. To have an expanded Phase 1 when you've already met all the goals of the study, for scientific reasons and hopefully for better patient results, is a great thing. We want to characterize the compound more completely, and we want the physicians to understand it as well. This is unusual, and this does not happen frequently, and it's a real honor."
http://www.thelifesciencesreport.com/pub/na/a...-jorgensen
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
